SelectScience InterviewsLife Sciences
Predict anticancer efficacy with a new *in vitro* 3D modeling platform
18 May 2021
Watch this presentation by Dr. Kolin Hribar, Founder and CEO, Cypre, and Dr. Julia Schueler, Research Director, Charles River Laboratories, titled: Predict anticancer efficacy with a new in vitro 3D modeling platform. This talk was presented at the SelectScience® Virtual Cancer and Immunology Research Summit 2021.
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
